Investors

Oncopeptides strives to ensure that analysts, investors, shareholders and financial media are provided with correct information to enhance understanding of our operations.

Webcast updated OCEAN results

Oncopeptides hosted a webcast on July 8, 2021, at 11:00 (CET). The event was hosted by CEO Marty J Duvall, CSO Jakob Lindberg, and CMO Klaas Bakker. 

Investors, financial analysts and media were invited to participate in the webcast with a QnA session. The presentation was held in English and was recorded.

More info, presentation and link to recorded webcast

Webcast - OCEAN topline results

Oncopeptides presented positive topline results from the phase 3 OCEAN and hosted a webcast May 25, 2021, at 11:00 (CET). 

The webcast included presentations by CEO Marty J Duvall, CSO Jakob Lindberg, CMO Klaas Bakker and Anders Martin-Löf CFO. The webcast was recorded.

More info, presentation and the webcast link

CEO Marty J Duvall summurizes the Year 2020

Our vision is to bring hope to In brief patients through passionate people, innovative science, and transformative medicines.

Released

Interim report Q1 2021

”A strong start for PEPAXTO in the US”

CEO Marty J Duvall

 

See the Webcast


For further information, please contact:

Linda Holmström
Director of Investor Relations

Profile image
Upcoming events

Upcoming events

View calendar

FDA approval of PEPAXTO - Webcast

In conjunction with the FDA approval of PEPAXTO, Oncopeptides hosted a webcast Monday March 1, 2021, including presentations by CEO Marty J Duvall, CSO Jakob Lindberg, CMO Klaas Bakker, and CFO Anders Martin-Löf. The webcast was recorded. 

More information

Released

Annual Report 2020

“The past year was a transformational year for Oncopeptides  highlighted by the FDA´s priority review of our NDA submission, which paved the way for an accelerated approval in the U.S. in early 2021.”

Marty J Duvall, CEO

 

Click here to watch the film where CEO Marty J Duvall summarizes a transformational year.

 

Annual Report 2020 - online version

 

For further information, please contact:

Linda Holmström
Director of Investor Relations

Profile image
CEO Marty J Duvall interviewed in Di.TV

CEO Marty J Duvall interviewed by Di.TV

In conjunction with the FDA approval, Oncopeptides' CEO Marty J Duvall was interviewed by the Swedish economy TV channel Di.TV Börsmorgon. See the interview (after about 30 sek the interview turns into English). 

See the interview

Presentations

See our latest Investor presentations To the archive

Oncopeptides via e-mail

Get our latest updates straight to your inbox. Unsubscribe at anytime.

This site is protected by reCAPTCHA & the Google Privacy Policy & Terms of Service  apply.